Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility to provide advanced extracellular vesicles-focused analytical services
https://www.exosomics.eu About NanoFCM NanoFCM Inc. is a privately-held company based in Xiamen, China which focuses on the development of high-performance analytical instruments. It has developed a next-generation nanoparticle analysis platform, the NanoAnalyzer, based on nano-flow cytometry. It is unique in its ability to deliver comprehensive measurement (size, concentration and phenotyping) down to 10-40nm, depending on the nature of the substrate. Its high-throughput operation, enables the processing of large numbers of samples required in clinical studies, cutting down the time to publication or to market, whereas its high-sensitivity and high-resolution performance increase the certainty of result. The NanoAnalyzer has already been identified as the new platform of choice for extracellular vesicles analysis, and is finding increased appeal in the analysis of gene therapy vectors, nanoparticle carriers, virus, mitochondria, bacteria and functionalised gold nanoparticles.
https://www.nanofcm.com/
Editor Details
-
Company:
- Life Science Newswire
-
Name:
- Leigh Dilley
- Email:
-
Telephone:
- +441223627120
- Website: